Progress of SARS-CoV-2 Main protease peptide-like inhibitors.

导出 LinkOut

翻译打印收藏纠错

作者： Xiaoyong,Liu ^[1] ; Xiaoli,Ren ^[1] ; Miao,Hua ^[2] ; Fang,Liu ^[3] ; Xiaoping,Ren ^[1] ; Chaoya,Sui ^[1] ; Qing,Li ^[1] ; Fen,Luo ^[1] ; Zhiyong,Jiang ^[1] ; Ziqiao,Xia ^[1] ; Jingxia,Chen ^[1] ; Bing,Yang ^[1]

作者单位： College of Environment and Quality Inspection, Chongqing Chemical Industry Vocational College, Chongqing, China. ^[1] Chongqing Experimental School, Chongqing, China. ^[2] Biomedical Analysis and Testing Center, College of Basic Medicine, Third Military Medical University, Chongqing, China. ^[3]

关键词 Mpro SARS-CoV-2 peptide-like inhibitor structure

主题词人类(Humans);病毒非结构蛋白质类(Viral Nonstructural Proteins);抗病毒药(Antiviral Agents);肽类(Peptides);蛋白酶抑制药(Protease Inhibitors)

DOI 10.1111/cbdd.14425

PMID 38082476

发布时间 2024-03-25

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交